Browse the full management transaction log of 위더스제약, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 위더스제약 has logged 14 public disclosures. The latest transaction was disclosed on 20 November 2024 (Purchase). Among the most active insiders: 권광영. All data is accessible without an account.
14
Insider Decl.
0
Thresholds
·
10 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.